Key facts
- This page summarizes Elizabeth Bhatt's Form 4 filing for Applied Molecular Transport Inc..
- 2 reported transactions and 1 derivative row are listed below.
- Accepted by SEC: 16 Feb 2022, 18:55.
Elizabeth Bhatt - 15 Feb 2022 Form 4 Insider Report for Applied Molecular Transport Inc.
- Reporting relationship
- Chief Bus. & Strategy Officer
- Issuer ticker
- N/A
- Reported as of
- 15 Feb 2022
- Net transaction value
- $0
- SEC form
- 4
- Accepted by SEC
- 16 Feb 2022, 18:55:06 UTC
- Prior SEC filing
- 06 Jan 2022
- Next SEC filing
- 13 Jun 2022
- Source filing
- View source filing
- Reporting owner signature
- /s/ Brandon Hants Attorney-in-Fact for Elizabeth Bhatt
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Elizabeth Bhatt filed Form 4 for Applied Molecular Transport Inc. on 16 Feb 2022.
Change
- Previous filing in this sequence was filed on 06 Jan 2022.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
AMTI
transaction
Common Stock
Award
- Transaction value
- $0
- Shares
- +17,250
- Change %
- +55%
- Price
- $0.000000
- Shares after
- 48,750
- Date
- 15 Feb 2022
- Ownership
- Direct
- Footnotes
- F1
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
AMTI
transaction
Derivative
Stock Option (Right to Buy)
Award
- Transaction value
- $0
- Shares
- +80,500
- Change %
- Price
- $0.000000
- Shares after
- 80,500
- Date
- 15 Feb 2022
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 80,500
- Exercise price
- $8.29
- Footnotes
- F2
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 2 footnotes
Footnote F1
These securities are Restricted Stock Units (RSUs). Each RSU represents a contingent right to receive one shares of the Issuer's Common Stock. 5/48ths of the RSUs shall vest on June 1, 2022 and 1/16th of the RSUs shall vest quarterly thereafter, subject to the Reporting Person continuing as a service provider through each such date.
Footnote F2
1/48th of the shares subject to the option shall become vested and exercisable on the Exercisable Date set forth above and 1/48th of the shares subject to the option shall continue to vest each month thereafter, provided that Reporting Person is a service provider to the Issuer as of each such vesting date.